Back to Journals » Drug Design, Development and Therapy » Volume 13

Original Research

YB-1 modulates the drug resistance of glioma cells by activation of MDM2/p53 pathway

         
Total article views   Abstract views HTML views PDF downloads Totals
5,442 Dovepress* 4,477 486+ 1,016 4,963
PubMed Central* 0 479 154 479
Totals 4,477 965 1,170 5,442
*Since 14 January 2019
+Since July 2016

View citations on PubMed Central and Google Scholar